Page last updated: 2024-11-04

etiron and Blood Pressure, Low

etiron has been researched along with Blood Pressure, Low in 2 studies

etiron: a nitric oxide synthase inhibitor; RN given refers to parent cpd; structure

Research Excerpts

ExcerptRelevanceReference
" Adverse events were recorded from study drug initiation through 30 days after the operation."2.73Nitric oxide synthase inhibitor (MTR-105) during open-heart surgery. A pilot double-blind placebo-controlled study of hemodynamic effects and safety. ( Borer, JS; Ciubotaru, A; Manolache, G; Sasson, L; Schachner, A; Ureche, A, 2008)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sasson, L1
Ureche, A1
Manolache, G1
Ciubotaru, A1
Borer, JS1
Schachner, A1
Booke, M1
Hinder, F1
Traber, LD1
McGuire, R1
Traber, DL1

Trials

1 trial available for etiron and Blood Pressure, Low

ArticleYear
Nitric oxide synthase inhibitor (MTR-105) during open-heart surgery. A pilot double-blind placebo-controlled study of hemodynamic effects and safety.
    Cardiology, 2008, Volume: 111, Issue:3

    Topics: Adult; Aged; Blood Pressure; Cardiac Surgical Procedures; Cardiovascular Diseases; Double-Blind Meth

2008

Other Studies

1 other study available for etiron and Blood Pressure, Low

ArticleYear
S-ethylisothiourea, a nonamino acid inhibitor of nitric oxide synthase, reverses septic vasodilation in sheep.
    Shock (Augusta, Ga.), 1995, Volume: 4, Issue:4

    Topics: Animals; Cardiac Output; Enzyme Inhibitors; Female; Hemodynamics; Hypotension; Infusions, Intravenou

1995